Chk1-mediated phosphorylation of Cdh1 promotes the SCF
Journal
Cell death & disease
ISSN: 2041-4889
Titre abrégé: Cell Death Dis
Pays: England
ID NLM: 101524092
Informations de publication
Date de publication:
28 04 2020
28 04 2020
Historique:
received:
20
08
2019
accepted:
09
04
2020
revised:
01
04
2020
entrez:
30
4
2020
pubmed:
30
4
2020
medline:
1
4
2021
Statut:
epublish
Résumé
APC/C
Identifiants
pubmed: 32345958
doi: 10.1038/s41419-020-2493-1
pii: 10.1038/s41419-020-2493-1
pmc: PMC7188793
doi:
Substances chimiques
Cdh1 Proteins
0
Cell Cycle Proteins
0
Ubiquitin
0
Checkpoint Kinase 1
EC 2.7.11.1
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
298Subventions
Organisme : NIGMS NIH HHS
ID : R01 GM112895
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA016058
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM108743
Pays : United States
Organisme : NCI NIH HHS
ID : R03 CA227206
Pays : United States
Organisme : NCRR NIH HHS
ID : S10 RR031537
Pays : United States
Références
Benanti, J. A. Coordination of cell growth and division by the ubiquitin-proteasome system. Semin. Cell Dev. Biol. 23, 492–498 (2012).
pubmed: 22542766
pmcid: 3398185
doi: 10.1016/j.semcdb.2012.04.005
Zheng, N., Wang, Z. & Wei, W. Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins. Int J. Biochem. Cell Biol. 73, 99–110 (2016).
pubmed: 26860958
pmcid: 4798898
doi: 10.1016/j.biocel.2016.02.005
Teixeira, L. K. & Reed, S. I. Ubiquitin ligases and cell cycle control. Annu. Rev. Biochem. 82, 387–414 (2013).
pubmed: 23495935
doi: 10.1146/annurev-biochem-060410-105307
pmcid: 23495935
Gilberto, S. & Peter, M. Dynamic ubiquitin signaling in cell cycle regulation. J. Cell Biol. 216, 2259–2271 (2017).
pubmed: 28684425
pmcid: 5551716
doi: 10.1083/jcb.201703170
Kernan, J., Bonacci, T. & Emanuele, M. J. Who guards the guardian? Mechanisms that restrain APC/C during the cell cycle. Biochim. Biophys. Acta Mol. Cell Res. 1865, 1924–1933 (2018).
pubmed: 30290241
pmcid: 6198803
doi: 10.1016/j.bbamcr.2018.09.011
Zhou, Z., He, M., Shah, A. A. & Wan, Y. Insights into APC/C: from cellular function to diseases and therapeutics. Cell Div. 11, 9 (2016).
pubmed: 27418942
pmcid: 4944252
doi: 10.1186/s13008-016-0021-6
Skaar, J. R. & Pagano, M. Control of cell growth by the SCF and APC/C ubiquitin ligases. Curr. Opin. Cell Biol. 21, 816–824 (2009).
pubmed: 19775879
pmcid: 2805079
doi: 10.1016/j.ceb.2009.08.004
Frescas, D. & Pagano, M. Deregulated proteolysis by the F-box proteins SKP2 and beta-TrCP: tipping the scales of cancer. Nat. Rev. Cancer 8, 438–449 (2008).
pubmed: 18500245
pmcid: 2711846
doi: 10.1038/nrc2396
Kramer, E. R., Scheuringer, N., Podtelejnikov, A. V., Mann, M. & Peters, J. M. Mitotic regulation of the APC activator proteins CDC20 and CDH1. Mol. Biol. Cell 11, 1555–1569 (2000).
pubmed: 10793135
pmcid: 14867
doi: 10.1091/mbc.11.5.1555
Fang, G., Yu, H. & Kirschner, M. W. Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol. Cell 2, 163–171 (1998).
pubmed: 9734353
doi: 10.1016/S1097-2765(00)80126-4
pmcid: 9734353
Visintin, R., Prinz, S. & Amon, A. CDC20 and CDH1: a family of substrate-specific activators of APC-dependent proteolysis. Science 278, 460–463 (1997).
pubmed: 9334304
doi: 10.1126/science.278.5337.460
pmcid: 9334304
Qiao, X., Zhang, L., Gamper, A. M., Fujita, T. & Wan, Y. APC/C-Cdh1. Cell Cycle 9, 3904–3912 (2010).
pubmed: 20935501
pmcid: 3047751
doi: 10.4161/cc.9.19.13585
Harper, J. W., Burton, J. L. & Solomon, M. J. The anaphase-promoting complex: it’s not just for mitosis any more. 16, 2179-2206 (2002)..
Engelbert, D., Schnerch, D., Baumgarten, A. & Wasch, R. The ubiquitin ligase APC(Cdh1) is required to maintain genome integrity in primary human cells. Oncogene 27, 907–917 (2008).
pubmed: 17700535
doi: 10.1038/sj.onc.1210703
pmcid: 17700535
Bassermann, F. et al. The Cdc14B-Cdh1-Plk1 axis controls the G2 DNA-damage-response checkpoint. Cell 134, 256–267 (2008).
pubmed: 18662541
pmcid: 2591934
doi: 10.1016/j.cell.2008.05.043
Garcia-Higuera, I. et al. Genomic stability and tumour suppression by the APC/C cofactor Cdh1. Nat. Cell Biol. 10, 802–811 (2008).
pubmed: 18552834
doi: 10.1038/ncb1742
pmcid: 18552834
Ke, P. Y., Kuo, Y. Y., Hu, C. M. & Chang, Z. F. Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability. Genes Dev. 19, 1920–1933 (2005).
pubmed: 16103219
pmcid: 1186191
doi: 10.1101/gad.1322905
Ross, K. E. & Cohen-Fix, O. The role of Cdh1p in maintaining genomic stability in budding yeast. Genetics 165, 489–503 (2003).
pubmed: 14573464
pmcid: 1462781
Sorensen, C. S. et al. Nonperiodic activity of the human anaphase-promoting complex-Cdh1 ubiquitin ligase results in continuous DNA synthesis uncoupled from mitosis. Mol. Cell Biol. 20, 7613–7623 (2000).
pubmed: 11003657
pmcid: 86321
doi: 10.1128/MCB.20.20.7613-7623.2000
Sudo, T. et al. Activation of Cdh1-dependent APC is required for G1 cell cycle arrest and DNA damage-induced G2 checkpoint in vertebrate cells. EMBO J. 20, 6499–6508 (2001).
pubmed: 11707420
pmcid: 125730
doi: 10.1093/emboj/20.22.6499
Wasch, R., Robbins, J. A. & Cross, F. R. The emerging role of APC/CCdh1 in controlling differentiation, genomic stability and tumor suppression. Oncogene 29, 1–10 (2010).
pubmed: 19826416
doi: 10.1038/onc.2009.325
pmcid: 19826416
Penas, C., Ramachandran, V. & Ayad, N. G. The APC/C ubiquitin ligase: from cell biology to tumorigenesis. Front. Oncol. 1, 60–60 (2012).
pubmed: 22655255
pmcid: 3356048
doi: 10.3389/fonc.2011.00060
Lehman, N. L. et al. Oncogenic regulators and substrates of the anaphase promoting complex/cyclosome are frequently overexpressed in malignant tumors. Am. J. Pathol. 170, 1793–1805 (2007).
pubmed: 17456782
pmcid: 1854971
doi: 10.2353/ajpath.2007.060767
Lukas, C. et al. Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex. Nature 401, 815–818 (1999).
pubmed: 10548110
doi: 10.1038/44611
pmcid: 10548110
Keck, J. M. et al. Cyclin E overexpression impairs progression through mitosis by inhibiting APC(Cdh1). J. Cell Biol. 178, 371–385 (2007).
pubmed: 17664332
pmcid: 2064850
doi: 10.1083/jcb.200703202
Jaspersen, S. L., Charles, J. F. & Morgan, D. O. Inhibitory phosphorylation of the APC regulator Hct1 is controlled by the kinase Cdc28 and the phosphatase Cdc14. Curr. Biol. 9, 227–236 (1999).
pubmed: 10074450
doi: 10.1016/S0960-9822(99)80111-0
pmcid: 10074450
Zachariae, W., Schwab, M., Nasmyth, K. & Seufert, W. Control of cyclin ubiquitination by CDK-regulated binding of Hct1 to the anaphase promoting complex. Science 282, 1721–1724 (1998).
pubmed: 9831566
doi: 10.1126/science.282.5394.1721
pmcid: 9831566
Sorensen, C. S. et al. A conserved cyclin-binding domain determines functional interplay between anaphase-promoting complex-Cdh1 and cyclin A-Cdk2 during cell cycle progression. Mol. Cell Biol. 21, 3692–3703 (2001).
pubmed: 11340163
pmcid: 87003
doi: 10.1128/MCB.21.11.3692-3703.2001
Chang, L., Zhang, Z., Yang, J., McLaughlin, S. H. & Barford, D. Atomic structure of the APC/C and its mechanism of protein ubiquitination. Nature 522, 450–454 (2015).
pubmed: 26083744
pmcid: 4608048
doi: 10.1038/nature14471
Lau, A. W. et al. Regulation of APC(Cdh1) E3 ligase activity by the Fbw7/cyclin E signaling axis contributes to the tumor suppressor function of Fbw7. Cell Res. 23, 947–961 (2013).
pubmed: 23670162
pmcid: 3698637
doi: 10.1038/cr.2013.67
Choudhury, R. et al. APC/C and SCF(cyclin F) constitute a reciprocal feedback circuit controlling S-phase Entry. Cell Rep. 16, 3359–3372 (2016).
pubmed: 27653696
pmcid: 5111906
doi: 10.1016/j.celrep.2016.08.058
Listovsky, T. et al. Mammalian Cdh1/Fzr mediates its own degradation. EMBO J. 23, 1619–1626 (2004).
pubmed: 15029244
pmcid: 391060
doi: 10.1038/sj.emboj.7600149
Fukushima, H. et al. SCF-mediated Cdh1 degradation defines a negative feedback system that coordinates cell-cycle progression. Cell Rep. 4, 803–816 (2013).
pubmed: 23972993
doi: 10.1016/j.celrep.2013.07.031
pmcid: 23972993
Yamada, M. et al. ATR-Chk1-APC/CCdh1-dependent stabilization of Cdc7-ASK (Dbf4) kinase is required for DNA lesion bypass under replication stress. Genes Dev. 27, 2459–2472 (2013).
pubmed: 24240236
pmcid: 3841735
doi: 10.1101/gad.224568.113
Jin, J. et al. SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. Genes Dev. 17, 3062–3074 (2003).
pubmed: 14681206
pmcid: 305258
doi: 10.1101/gad.1157503
Busino, L. et al. Degradation of Cdc25A by beta-TrCP during S phase and in response to DNA damage. Nature 426, 87–91 (2003).
pubmed: 14603323
doi: 10.1038/nature02082
pmcid: 14603323
Gao, D. et al. Cdh1 regulates cell cycle through modulating the claspin/Chk1 and the Rb/E2F1 pathways. Mol. Biol. Cell 20, 3305–3316 (2009).
pubmed: 19477924
pmcid: 2710831
doi: 10.1091/mbc.e09-01-0092
Sigl, R. et al. Loss of the mammalian APC/C activator FZR1 shortens G1 and lengthens S phase but has little effect on exit from mitosis. J. Cell Sci. 122, 4208–4217 (2009).
pubmed: 19861496
doi: 10.1242/jcs.054197
pmcid: 19861496
Moiseeva, T. N. et al. An ATR and CHK1 kinase signaling mechanism that limits origin firing during unperturbed DNA replication. Proc. Natl Acad. Sci. USA 116, 13374–13383 (2019).
pubmed: 31209037
doi: 10.1073/pnas.1903418116
pmcid: 31209037
Zhang, L. et al. Proteolysis of Rad17 by Cdh1/APC regulates checkpoint termination and recovery from genotoxic stress. EMBO J. 29, 1726–1737 (2010).
pubmed: 20424596
pmcid: 2876963
doi: 10.1038/emboj.2010.55
Faustrup, H., Bekker-Jensen, S., Bartek, J., Lukas, J. & Mailand, N. USP7 counteracts SCFbetaTrCP- but not APCCdh1-mediated proteolysis of Claspin. J. Cell Biol. 184, 13–19 (2009).
pubmed: 19124652
pmcid: 2615094
doi: 10.1083/jcb.200807137
Tse, A. N. et al. CHIR-124, a novel potent inhibitor of Chk1, potentiates the cytotoxicity of topoisomerase I poisons in vitro and in vivo. Clin. Cancer Res. 13, 591–602 (2007).
pubmed: 17255282
doi: 10.1158/1078-0432.CCR-06-1424
pmcid: 17255282
Liu, W., Li, W., Fujita, T., Yang, Q. & Wan, Y. Proteolysis of CDH1 enhances susceptibility to UV radiation-induced apoptosis. Carcinogenesis 29, 263–272 (2008).
pubmed: 18174259
doi: 10.1093/carcin/bgm251
pmcid: 18174259
Liu, Q. et al. Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint. Genes Dev. 14, 1448–1459 (2000).
pubmed: 10859164
pmcid: 316686
doi: 10.1101/gad.840500
Patil, M., Pabla, N. & Dong, Z. Checkpoint kinase 1 in DNA damage response and cell cycle regulation. Cell. Mol. life Sci.: CMLS 70, 4009–4021 (2013).
pubmed: 23508805
doi: 10.1007/s00018-013-1307-3
pmcid: 23508805
Zachos, G., Rainey, M. D. & Gillespie, D. A. Chk1-dependent S-M checkpoint delay in vertebrate cells is linked to maintenance of viable replication structures. Mol. Cell Biol. 25, 563–574 (2005).
pubmed: 15632059
pmcid: 543419
doi: 10.1128/MCB.25.2.563-574.2005
Zhang, Y. & Hunter, T. Roles of Chk1 in cell biology and cancer therapy. Int J. Cancer 134, 1013–1023 (2014).
pubmed: 23613359
doi: 10.1002/ijc.28226
pmcid: 23613359
Zhao, H. & Piwnica-Worms, H. ATR-mediated checkpoint pathways regulate phosphorylation and activation of human Chk1. Mol. Cell. Biol. 21, 4129–4139 (2001).
pubmed: 11390642
pmcid: 87074
doi: 10.1128/MCB.21.13.4129-4139.2001
Petermann, E. & Caldecott, K. W. Evidence that the ATR/Chk1 pathway maintains normal replication fork progression during unperturbed S phase. Cell Cycle 5, 2203–2209 (2006).
pubmed: 16969104
doi: 10.4161/cc.5.19.3256
pmcid: 16969104
Petermann, E. et al. Chk1 requirement for high global rates of replication fork progression during normal vertebrate S phase. Mol. Cell Biol. 26, 3319–3326 (2006).
pubmed: 16581803
pmcid: 1446959
doi: 10.1128/MCB.26.8.3319-3326.2006
Maya-Mendoza, A., Petermann, E., Gillespie, D. A., Caldecott, K. W. & Jackson, D. A. Chk1 regulates the density of active replication origins during the vertebrate S phase. EMBO J. 26, 2719–2731 (2007).
pubmed: 17491592
pmcid: 1888675
doi: 10.1038/sj.emboj.7601714
Sorensen, C. S., Syljuasen, R. G., Lukas, J. & Bartek, J. ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage. Cell Cycle 3, 941–945 (2004).
pubmed: 15190204
doi: 10.4161/cc.3.7.972
pmcid: 15190204
Winston, J. T. et al. The SCFbeta-TRCP-ubiquitin ligase complex associates specifically with phosphorylated destruction motifs in IkappaBalpha and beta-catenin and stimulates IkappaBalpha ubiquitination in vitro. Genes Dev. 13, 270–283 (1999).
pubmed: 9990852
pmcid: 316433
doi: 10.1101/gad.13.3.270
Hart, M. et al. The F-box protein beta-TrCP associates with phosphorylated beta-catenin and regulates its activity in the cell. Curr. Biol. 9, 207–210 (1999).
pubmed: 10074433
doi: 10.1016/S0960-9822(99)80091-8
pmcid: 10074433
Yaron, A. et al. Identification of the receptor component of the IkappaBalpha-ubiquitin ligase. Nature 396, 590–594 (1998).
pubmed: 9859996
doi: 10.1038/25159
pmcid: 9859996
De, K. et al. Hyperphosphorylation of CDH1 in glioblastoma cancer stem cells attenuates APC/C(CDH1) activity and pharmacologic inhibition of APC/C(CDH1/CDC20) compromises viability. Mol. Cancer Res 17, 1519–1530 (2019).
pubmed: 31036696
doi: 10.1158/1541-7786.MCR-18-1361
pmcid: 31036696
Han, X. et al. Conformational change of human checkpoint kinase 1 (Chk1) induced by DNA damage. J. Biol. Chem. 291, 12951–12959 (2016).
pubmed: 27129240
pmcid: 4933214
doi: 10.1074/jbc.M115.713248
Huh, J. & Piwnica-Worms, H. CRL4(CDT2) targets CHK1 for PCNA-independent destruction. Mol. Cell Biol. 33, 213–226 (2013).
pubmed: 23109433
pmcid: 3554108
doi: 10.1128/MCB.00847-12
Zhang, Y. W. et al. Genotoxic stress targets human Chk1 for degradation by the ubiquitin-proteasome pathway. Mol. Cell 19, 607–618 (2005).
pubmed: 16137618
doi: 10.1016/j.molcel.2005.07.019
pmcid: 16137618
Mailand, N., Bekker-Jensen, S., Bartek, J. & Lukas, J. Destruction of Claspin by SCFbetaTrCP restrains Chk1 activation and facilitates recovery from genotoxic stress. Mol. Cell 23, 307–318 (2006).
pubmed: 16885021
doi: 10.1016/j.molcel.2006.06.016
pmcid: 16885021
Peschiaroli, A. et al. SCFbetaTrCP-mediated degradation of Claspin regulates recovery from the DNA replication checkpoint response. Mol. Cell 23, 319–329 (2006).
pubmed: 16885022
doi: 10.1016/j.molcel.2006.06.013
pmcid: 16885022
Mamely, I. et al. Polo-like kinase-1 controls proteasome-dependent degradation of Claspin during checkpoint recovery. Curr. Biol. 16, 1950–1955 (2006).
pubmed: 16934469
doi: 10.1016/j.cub.2006.08.026
pmcid: 16934469
Leung-Pineda, V., Huh, J. & Piwnica-Worms, H. DDB1 targets Chk1 to the Cul4 E3 ligase complex in normal cycling cells and in cells experiencing replication stress. Cancer Res. 69, 2630–2637 (2009).
pubmed: 19276361
pmcid: 2776040
doi: 10.1158/0008-5472.CAN-08-3382
Zielke, N., Querings, S., Rottig, C., Lehner, C. & Sprenger, F. The anaphase-promoting complex/cyclosome (APC/C) is required for rereplication control in endoreplication cycles. Genes Dev. 22, 1690–1703 (2008).
pubmed: 18559483
pmcid: 2428065
doi: 10.1101/gad.469108
Verschuren, E. W., Ban, K. H., Masek, M. A., Lehman, N. L. & Jackson, P. K. Loss of Emi1-dependent anaphase-promoting complex/cyclosome inhibition deregulates E2F target expression and elicits DNA damage-induced senescence. Mol. Cell Biol. 27, 7955–7965 (2007).
pubmed: 17875940
pmcid: 2169152
doi: 10.1128/MCB.00908-07
Machida, Y. J. & Dutta, A. The APC/C inhibitor, Emi1, is essential for prevention of rereplication. Genes Dev. 21, 184–194 (2007).
pubmed: 17234884
pmcid: 1770901
doi: 10.1101/gad.1495007
Gheghiani, L., Loew, D., Lombard, B., Mansfeld, J. & Gavet, O. PLK1 activation in late G2 sets up commitment to mitosis. Cell Rep. 19, 2060–2073 (2017).
pubmed: 28591578
doi: 10.1016/j.celrep.2017.05.031
pmcid: 28591578
Melixetian, M., Klein, D. K., Sorensen, C. S. & Helin, K. NEK11 regulates CDC25A degradation and the IR-induced G2/M checkpoint. Nat. Cell Biol. 11, 1247–1253 (2009).
pubmed: 19734889
doi: 10.1038/ncb1969
pmcid: 19734889
Chu, Z., Eshaghi, M., Poon, S. Y. & Liu, J. A Cds1-mediated checkpoint protects the MBF activator Rep2 from ubiquitination by anaphase-promoting complex/cyclosome-Ste9 at S-phase arrest in fission yeast. Mol. Cell Biol. 29, 4959–4970 (2009).
pubmed: 19596787
pmcid: 2738293
doi: 10.1128/MCB.00562-09
Venere, M. et al. The mitotic kinesin KIF11 is a driver of invasion, proliferation, and self-renewal in glioblastoma. Sci. Transl. Med. 7, 304ra143 (2015).
pubmed: 26355032
pmcid: 4743764
doi: 10.1126/scitranslmed.aac6762
Ahmed, S. U. et al. Selective inhibition of parallel DNA damage response pathways optimizes radiosensitization of glioblastoma stem-like cells. Cancer Res 75, 4416–4428 (2015).
pubmed: 26282173
doi: 10.1158/0008-5472.CAN-14-3790
pmcid: 26282173
Burdova, K. et al. E2F1 proteolysis via SCF-cyclin F underlies synthetic lethality between cyclin F loss and Chk1 inhibition. EMBO J. 38, e101443 (2019).
pubmed: 31424118
pmcid: 6792013
doi: 10.15252/embj.2018101443
Burrows, A. C., Prokop, J. & Summers, M. K. Skp1-Cul1-F-box ubiquitin ligase (SCF(betaTrCP))-mediated destruction of the ubiquitin-specific protease USP37 during G2-phase promotes mitotic entry. J. Biol. Chem. 287, 39021–39029 (2012).
pubmed: 23027877
pmcid: 3493943
doi: 10.1074/jbc.M112.390328
Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).
pubmed: 17076895
pmcid: 1794559
doi: 10.1186/gb-2006-7-10-r100